Trial Profile
A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Sulfamethoxazole Administered Alone and in Combination With MMX Mesalazine/Mesalamine in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2021
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary) ; Cotrimoxazole
- Indications Bacterial infections; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Shire
- 12 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 17 Nov 2011 Actual initiation date (Nov 2011) added as reported by ClinicalTrials.gov.